
Steven Ferenc Polyak MD
Advanced Endoscopic Interventional, Inflammatory Bowel Disease
University of Iowa
Join to view full profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-4901
Fax+1 319-384-8559
Dr. Polyak is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Polyak is a gastroenterologist in Iowa City, IA and is affiliated with multiple hospitals in the area, including University of Iowa Hospitals and Clinics and Iowa City VA Health Care System. He received his medical degree from Mount Sinai School of Medicine and has been in practice 19 years. He specializes in advanced endoscopic interventional and inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.
Education & Training
University of FloridaFellowship, Gastroenterology, 2001 - 2004
Vanderbilt University Medical CenterResidency, Internal Medicine, 1998 - 2001
Icahn School of Medicine at Mount SinaiClass of 1998
Certifications & Licensure
IA State Medical License 2010 - 2027
FL State Medical License 2004 - 2011
TN State Medical License 2000 - 2005
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2012-2014, 2016-2017
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
- Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
- A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsClinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.Hans H Herfarth, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Clinical and Translational Gastroenterology. 2024-03-01 - Plaque-Like Lesions in the Gastrointestinal Tract.Katelin Durham, Xiaocen Zhang, Yiqin Xiong, Aditi Reddy, Steven Polyak
ACG Case Reports Journal. 2023-08-01 - 23 citationsTofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.Millie D Long, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Inflammatory Bowel Diseases. 2023-04-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: